Literature DB >> 26472474

Energy homeostasis genes and survival after breast cancer diagnosis: the Breast Cancer Health Disparities Study.

Andrew J Pellatt, Abbie Lundgreen, Roger K Wolff, Lisa Hines, Esther M John, Martha L Slattery.   

Abstract

PURPOSE: The leptin-signaling pathway and other genes involved in energy homeostasis (EH) have been examined in relation to breast cancer risk as well as to obesity. We test the hypothesis that genetic variation in EH genes influences survival after diagnosis with breast cancer and that body mass index (BMI) will modify that risk.
METHODS: We evaluated associations between 10 EH genes and survival among 1,186 non-Hispanic white and 1,155 Hispanic/Native American women diagnosed with breast cancer. Percent Native American (NA) ancestry was determined from 104 ancestry-informative markers. Adaptive rank truncation product (ARTP) was used to determine gene and pathway significance.
RESULTS: The overall EH pathway was marginally significant for all-cause mortality among women with low NA ancestry (P(ARTP) = 0.057). Within the pathway, ghrelin(GHRL) and leptin receptor (LEPR) were significantly associated with all-cause mortality (P(ARTP) = 0.035 and 0.007, respectively). The EH pathway was significantly associated with breast cancer-specific mortality among women with low NA ancestry (P(ARTP) = 0.038). Three genes cholecystokinin (CCK), GHRL, and LEPR were significantly associated with breast cancer-specific mortality among women with low NA ancestry (P(ARTP) = 0.046,0.015, and 0.046, respectively), while neuropeptide Y (NPY) was significantly associated with breast cancer-specific mortality among women with higher NA ancestry(P(ARTP) = 0.038). BMI did not modify these associations.
CONCLUSIONS: Our data support our hypothesis that certain EH genes influence survival after diagnosis with breast cancer; associations appear to be most important among women with low NA ancestry.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26472474      PMCID: PMC4833710          DOI: 10.1007/s10552-015-0681-6

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  49 in total

1.  Inference of population structure using multilocus genotype data.

Authors:  J K Pritchard; M Stephens; P Donnelly
Journal:  Genetics       Date:  2000-06       Impact factor: 4.562

2.  Inference of population structure using multilocus genotype data: linked loci and correlated allele frequencies.

Authors:  Daniel Falush; Matthew Stephens; Jonathan K Pritchard
Journal:  Genetics       Date:  2003-08       Impact factor: 4.562

3.  The expression of ghrelin O-acyltransferase (GOAT) in human tissues.

Authors:  Chung Thong Lim; Blerina Kola; Ashley Grossman; Márta Korbonits
Journal:  Endocr J       Date:  2011-06-04       Impact factor: 2.349

4.  Adipokines in plasma and breast tissues: associations with breast cancer risk factors.

Authors:  Adana A Llanos; Ramona G Dumitrescu; Catalin Marian; Kepher H Makambi; Scott L Spear; Bhaskar V S Kallakury; David J Perry; Rafael J Convit; Mary E Platek; Amy E Millen; Lucile L Adams-Campbell; Jo L Freudenheim; Peter G Shields
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-08-14       Impact factor: 4.254

5.  Lifetime physical activity and breast cancer risk in a multiethnic population: the San Francisco Bay area breast cancer study.

Authors:  Esther M John; Pamela L Horn-Ross; Jocelyn Koo
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-11       Impact factor: 4.254

6.  Diet and lifestyle factors interact with MAPK genes to influence survival: the Breast Cancer Health Disparities Study.

Authors:  Martha L Slattery; Lisa H Hines; Abbie Lundgreen; Kathy B Baumgartner; Roger K Wolff; Mariana C Stern; Esther M John
Journal:  Cancer Causes Control       Date:  2014-07-04       Impact factor: 2.506

Review 7.  Ghrelin: integrative neuroendocrine peptide in health and disease.

Authors:  James T Wu; John G Kral
Journal:  Ann Surg       Date:  2004-04       Impact factor: 12.969

8.  Leptin and leptin receptor polymorphisms are associated with increased risk and poor prognosis of breast carcinoma.

Authors:  Kaouther Snoussi; A Donny Strosberg; Noureddine Bouaouina; Slim Ben Ahmed; A Noureddine Helal; Lotfi Chouchane
Journal:  BMC Cancer       Date:  2006-02-20       Impact factor: 4.430

9.  Trypsin inhibitor from tamarindus indica L. seeds reduces weight gain and food consumption and increases plasmatic cholecystokinin levels.

Authors:  Joycellane Alline do Nascimento Campos Ribeiro; Alexandre Coellho Serquiz; Priscila Fabíola dos Santos Silva; Patrícia Batista Barra Medeiros Barbosa; Tarcísio Bruno Montenegro Sampaio; Raimundo Fernandes de Araújo Junior; Adeliana Silva de Oliveira; Richele Janaina Araújo Machado; Bruna Leal Lima Maciel; Adriana Ferreira Uchôa; Elizeu Antunes dos Santos; Ana Heloneida de Araújo Morais
Journal:  Clinics (Sao Paulo)       Date:  2015-02       Impact factor: 2.365

10.  Common genetic variations in the LEP and LEPR genes, obesity and breast cancer incidence and survival.

Authors:  Rebecca J Cleveland; Marilie D Gammon; Chang-Min Long; Mia M Gaudet; Sybil M Eng; Susan L Teitelbaum; Alfred I Neugut; Regina M Santella
Journal:  Breast Cancer Res Treat       Date:  2009-08-21       Impact factor: 4.872

View more
  4 in total

Review 1.  Ghrelin and Breast Cancer: Emerging Roles in Obesity, Estrogen Regulation, and Cancer.

Authors:  CheukMan Cherie Au; John B Furness; Kristy A Brown
Journal:  Front Oncol       Date:  2017-01-09       Impact factor: 6.244

Review 2.  Genetic Epidemiology of Breast Cancer in Latin America.

Authors:  Valentina A Zavala; Silvia J Serrano-Gomez; Julie Dutil; Laura Fejerman
Journal:  Genes (Basel)       Date:  2019-02-18       Impact factor: 4.096

Review 3.  Attribution of Ghrelin to Cancer; Attempts to Unravel an Apparent Controversy.

Authors:  Saeed Soleyman-Jahi; Fatemeh Sadeghi; Amin Pastaki Khoshbin; Leila Khani; Venus Roosta; Kazem Zendehdel
Journal:  Front Oncol       Date:  2019-10-16       Impact factor: 6.244

4.  Energy homeostasis genes modify the association between serum concentrations of IGF-1 and IGFBP-3 and breast cancer risk.

Authors:  Rocío Rodríguez-Valentín; Gabriela Torres-Mejía; Louis Martínez-Matsushita; Angélica Angeles-Llerenas; Liliana Gómez-Flores-Ramos; Roger K Wolff; Kathy B Baumgartner; Lisa M Hines; Elad Ziv; Lourdes Flores-Luna; Luisa Ma Sánchez-Zamorano; Eduardo Ortiz-Panozo; Martha L Slattery
Journal:  Sci Rep       Date:  2022-02-03       Impact factor: 4.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.